Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00029640 · ClinicalTrials.gov registry record

The Treatment of Children and Adolescents With Treatment-Resistant Depression

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
90
Enrollment target

NCT00029640 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 90 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00029640 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
90 participants
Enrollment target

Study Summary

This study seeks to learn about brain function in adolescents with depression and to determine whether adding lithium carbonate to antidepressant medication can reduce depression in children and adolescents. Functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS) will examine brain chemistry and function.

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2002-01
Est. Completion 2004-03

What the Registry Record Tells You About NCT00029640

The ClinicalTrials.gov registry entry for NCT00029640 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00029640 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00029640 about?

NCT00029640 is a clinical study titled "The Treatment of Children and Adolescents With Treatment-Resistant Depression". This study seeks to learn about brain function in adolescents with depression and to determine whether adding lithium carbonate to antidepressant medication can reduce depression in children and adolescents. Functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS) will ...

What is the current status of trial NCT00029640?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2002-01. Estimated completion is 2004-03.

Who is sponsoring clinical trial NCT00029640?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.